Miso Kim

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Topics

Body Composition

Tyrosine Kinase

Small Cell Lung Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Songji Oh, Jaemoon Koh, Tae Min Kim, Soyeon Kim, Jeonghwan Youk, Miso Kim, Bhumsuk Keam, Yoon Kyung Jeon, Ja-Lok Ku, Dong Wan Kim, Doo Hyun Chung, Dae Seog Heo
Transcriptomic heterogeneity of EGFR-mutant non-small cell lung cancer evolution towards small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Gruenwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime R Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, Maria Jose Mendez, Evgeny Kopyltsov, Sergey A Tjulandin, Teresa Alonso Gordoa, Vadim Kozlov, Anna Alyasova, Eric Winquist, Pablo Maroto, Miso Kim, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Karla Rodriguez-Lopez, Joseph Burgents, Cixin He, Chinyere E Okpara, Jodi-Ann Mckenzie, Toni K Choueiri, null null
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
William Kevin Kelly, Daniel Costin Danila, Chia-Chi Lin, Jae Lyun Lee, Nobuaki Matsubara, Patrick J Ward, Andrew J Armstrong, David W Pook, Miso Kim, Tanya Barauskas Dorff, Stefanie Fischer, Yung-Chang Lin, Lisa G Horvath, Christopher Sumey, Zhao Yang, Gabor Jurida, Kristen M Smith, Jamie N Connarn, Hweixian Leong Penny, Julia Stieglmaier, Leonard J Appleman
Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study. Cancer discovery (2023)
Ji Eun Park, Jaemin Jo, Jeonghwan Youk, Miso Kim, Soon Ho Yoon, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim
Prognostic utility of body composition parameters based on computed tomography analysis of advanced non-small cell lung cancer treated with immune checkpoint inhibitors. Insights into imaging 14 (1) (2023)
David W Pook, Daniel M Geynisman, Joan Carles, Filippo G De Braud, Anthony M Joshua, Jose-Luis Perez-Gracia, Casilda Llácer Pérez, Sang Joon Shin, Bruno Fang, Minal Barve, Maruzzo Marco, Sergio Bracarda, Miso Kim, Yannick Kerloeguen, Jorge Daniel Gallo, Sophia L Maund, Adam Harris, Kuan-Chieh Huang, Victor Poon, Dhruvitkumar S Sutaria, Howard Gurney
A phase Ib, open-label study evaluating the safety and efficacy of ipatasertib plus rucaparib in patients with metastatic castration-resistant prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
June Young Chun, Se Ik Kim, Eun Young Park, Sang-Yoon Park, Su-Jin Koh, Yongjun Cha, Heon Jong Yoo, Jae Young Joung, Hong Man Yoon, Bang Wool Eom, Chul Min Park, Ji-Youn Han, Miso Kim, Dae-Won Lee, Jae-Weon Kim, Bhumsuk Keam, Maria Lee, Tae Min Kim, Young Ju Choi, Yoon Jung Chang, Myong Cheol Lim
Cancer Patients' Willingness to Take COVID-19 Vaccination: A Nationwide Multicenter Survey in Korea. Cancers 13 (15) (2021)
Eun Hee Jung, Hee Ryeong Jang, Se Hyun Kim, Koung Jin Suh, Yu Jung Kim, Ju-Hyun Lee, Jin-Haeng Chung, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dong Wan Kim, Dae Seog Heo, Jong Seok Lee
Tumor LAG-3 and NY-ESO-1 expression predict durable clinical benefits of immune checkpoint inhibitors in advanced non-small cell lung cancer. Thoracic cancer 12 (5) (2021)
Ja Young Seo, Jeong-Yeal Ahn, Bhumsuk Keam, Miso Kim, Shinkyo Yoon, Jae Lyun Lee, Kownoh Park, Inkeun Park
Genotypic and Phenotypic Characteristics of Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Korean Patients. Annals of laboratory medicine 41 (2) (2021)
Hongsik Kim, Dong-Wan Kim, Miso Kim, Young Joo Lee, Hee Kyung Ahn, Jang Ho Cho, Il Hwan Kim, Yun-Gyoo Lee, Seong-Hoon Shin, Song Ee Park, Jiyoon Jung, Eun Joo Kang, Myung-Ju Ahn
Long-term outcomes in patients with advanced and/or metastatic non-small cell lung cancer who completed 2 years of immune checkpoint inhibitors or achieved a durable response after discontinuation without disease progression: Multicenter, real-world data (KCSG LU20-11). Cancer (2021)
Hyeyeon Chang, Yong-Won Shin, Bhumsuk Keam, Miso Kim, Seock-Ah Im, Soon Tae Lee
HLA-B27 association of autoimmune encephalitis induced by PD-L1 inhibitor. Annals of clinical and translational neurology 7 (11) (2020)